Eli Lilly
LLY
$726.31
Share price
-2.63%
Change (1 day)
96.35%
Change (1 year)
Categories
With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
Eli Lilly (LLY) - Total debt
Total debt on the balance sheet as of December 2023 : $25.22 B
According to Eli Lilly's latest financial reports the company's total debt is $25.22 B. A company’s total debt is the sum of all current and non-current debts.
Eli Lilly - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $25.22 B | 55.34% |
| 2022-12-31 | $16.23 B | -3.83% |
| 2021-12-31 | $16.88 B | 1.74% |
| 2020-12-31 | $16.59 B | 8.34% |
| 2019-12-31 | $15.31 B | 48.73% |
| 2018-12-31 | $10.29 B | -24.54% |
| 2017-12-31 | $13.64 B | 32.43% |
| 2016-12-31 | $10.30 B | 29.16% |
| 2015-12-31 | $7.97 B | -0.54% |
| 2014-12-31 | $8.02 B | 53.88% |
| 2013-12-31 | $5.21 B | -5.76% |
| 2012-12-31 | $5.53 B | -20.83% |
| 2011-12-31 | $6.98 B | 0.87% |
| 2010-12-31 | $6.92 B | 3.97% |
| 2009-12-31 | $6.66 B | -36.32% |
| 2008-12-31 | $10.46 B | 108.94% |
| 2007-12-31 | $5.00 B | 34.83% |
| 2006-12-31 | $3.71 B | -42.85% |
| 2005-12-31 | $6.49 B | -0.22% |
| 2004-12-31 | $6.51 B | 33.34% |
| 2003-12-31 | $4.88 B | -0.39% |
| 2002-12-31 | $4.90 B | 43.45% |
| 2001-12-31 | $3.41 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 16.28% | 🇺🇸 USA |
 Novartis NVS | $26.34 B | 4.45% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 180.85% | 🇺🇸 USA |
 AbbVie ABBV | $59.38 B | 135.42% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 156.14% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | -19.26% | 🇫🇷 France |
 Merck MRK | $35.05 B | 38.97% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $41.46 B | 64.37% | 🇺🇸 USA |
 AstraZeneca AZN | $28.62 B | 13.47% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $22.93 B | -9.07% | 🇬🇧 UK |